BDBM802080 (1R,2S,5S)-N-[3-amino-1- (cyclopropylmethyl)-2,3-dioxo-propyl]- 6,6-dimethyl-3-[(2S)-3-methyl-2-[(2,2,2- trifluoroacetyl)amino]butanoyl]-3- azabicyclo[3.1.0]hexane-2-carboxamide::US20260109672, Example 3

SMILES CC(C)[C@H](NC(=O)C(F)(F)F)C(=O)N1C[C@H]2[C@@H]([C@H]1C(=O)NC(CC1CC1)C(=O)C(N)=O)C2(C)C

InChI Key InChIKey=BQJISYWTAZRKRA-UHFFFAOYSA-N

Data  1 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 802080   

TargetReplicase polyprotein 1a(2019-nCoV)
Nxera Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 802080BDBM802080((1R,2S,5S)-N-[3-amino-1- (cyclopropylmethyl)-2,3-d...)
Affinity DataKi:  63.1nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/2/2026
Entry Details
US Patent